quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 24, 2026

As Tim Cook Steps Aside, What's Next for Apple?

View original at nasdaq.com
As Tim Cook Steps Aside, What's Next for Apple?…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Apple was right not to build its own car

    60% confidence
  • Service revenue was about 5% of Apple's business when Cook took over, now more than 25%

    60% confidence
  • AST SpaceMobile has $31 billion market cap for essentially a pre-revenue company with $1.2 billion revenue commitments

    60% confidence
  • AST SpaceMobile satellite that went into wrong orbit will be deorbited

    60% confidence
  • If you invested $1,000 in Netflix on December 17, 2004 based on Stock Advisor recommendation, you'd have $500,572

    60% confidence
  • Firefly Aerospace is beginning to look like a reliable launch partner

    60% confidence
  • If SpaceX were added to S&P 500 at $2 trillion valuation, it would account for almost 3% of the index's weight

    60% confidence
  • Bringing in a hardware engineer as CEO doesn't guarantee a new breakthrough product

    60% confidence
  • Getting the AI strategy right could be just as big as a new product launch for Apple

    60% confidence
  • Being behind the curve on AI innovation is one of the biggest challenges for Apple's new leadership

    60% confidence
  • We need to quickly decide how to handle large company IPOs because Anthropic and OpenAI are waiting

    60% confidence
  • Companies that establish themselves as reliable launch providers will succeed

    60% confidence
  • Index fund players would need to amass at least 20% stake in SpaceX if included in S&P 500

    60% confidence
  • AST SpaceMobile investment is speculative at best with a lot of execution risk

    60% confidence
  • AST SpaceMobile has just over $3 billion in cash to build out their satellite constellation

    60% confidence
  • Apple shares generated about 3,100% total returns under Tim Cook compared to 731% for S&P 500

    60% confidence
  • AST SpaceMobile is traded at a conservative 130 times future sales

    60% confidence
  • Tim Cook's lasting legacy is stability - he kept the plane on course

    60% confidence
  • Apple now has more than 1 billion paid subscriptions throughout its ecosystem

    60% confidence
  • There is about $2.8 trillion in passive S&P 500 index ETFs

    60% confidence
  • Having the customer is more valuable than having the AI model in two years

    60% confidence
  • Apple's profits are up about 700% since Tim Cook took over as CEO

    60% confidence
  • Apple is not among the 10 best stocks for investors to buy now according to Stock Advisor

    60% confidence
  • About 4 billion people on Earth live where cell coverage is not great

    60% confidence
  • Rocket Lab is the best space investment idea right now

    60% confidence
  • T-Mobile trades at 2.5 times sales

    60% confidence
  • AST SpaceMobile needs to complete 45 to 60 launches this year to start generating revenue

    60% confidence
  • If you invested $1,000 in Nvidia on April 15, 2005 based on Stock Advisor recommendation, you'd have $1,223,900

    60% confidence
  • There are not enough reliable launch partners right now in the space industry

    60% confidence
  • 30% of all assets under management in top 100 ETFs are allocated to S&P 500

    60% confidence

Data points we hold from this source

S&P 500 · total average return199 percent
SpaceX · valuation2 trillion_USD
SpaceX · sp500 weight3 percent
SpaceX · ipo raise amount90 USD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com